Atlas Trials

A Study Comparing the Blood Levels of Both Pegaspargase (S95014) Formulations (Liquid vs Lyophilized) in the Treatment of Paediatric Patients With Acute Lymphoblastic Leukemia (ALL)

Clinical trial NCT04954326 · COMPLETED

Trial details

NCT number
NCT04954326
Sponsor
Institut de Recherches Internationales Servier
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Lymphoblastic Leukemia
Start date
2021-05-07
Primary completion
2022-05-20
Enrollment
89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.